Can Hypothyroidism Cause Acute Central Serous Chorioretinopathy?

被引:2
|
作者
Ulas, Fatih [1 ]
Uyar, Enes [1 ]
Tekce, Hikmet [2 ]
Celebi, Serdal [1 ]
机构
[1] Abant Izzet Baysal Univ, Fac Med, Dept Ophthalmol, TR-14280 Bolu, Turkey
[2] Abant Izzet Baysal Univ, Fac Med, Dept Internal Med, Bolu, Turkey
关键词
Central serous chorioretinopathy; choroid; hypertension; hypothyroidism; mean arterial pressure; thyroid stimulating hormone; THYROID-HORMONE; RISK-FACTORS; HYPERTHYROIDISM; SECRETION; DISEASE;
D O I
10.1080/08820538.2019.1684524
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To evaluate selected systemic findings, especially thyroid functions, in acute central serous chorioretinopathy (CSC) patients. Materials and Methods: In all, 71 consecutive acute CSC patients who fulfilled the inclusion criteria and 70 age-matched healthy control subjects were included in the study. Systemic findings, including serum levels of thyroid hormones, thyroid stimulating hormone (TSH), mean arterial pressure (MAP), pulse rate, serum lipid levels and optical coherence tomography findings, were compared between the groups. Independent samples t-test was used for statistical analysis. Results: The mean ages of the CSC and control groups were 41.06 +/- 6.49 and 40.06 +/- 7.08 years old, respectively. Retinal thickness, choroidal thickness, TSH levels, pulse rate and MAP were significantly different between CSC patients and healthy control subjects (range of p values: <0.001-0.042). In the logistic regression analysis, MAP, serum triglyceride concentration and central choroidal thickness were positively associated with CSC (range of p values: <0.001-0.035). Conclusion: Acute CSC patients had significantly higher pulse rates and MAP and significantly thicker choroidal thickness than were found in healthy subjects. TSH levels were also significantly higher in CSC patients than in controls. Hence, hypothyroidism might be associated with CSC.
引用
收藏
页码:533 / 540
页数:8
相关论文
共 50 条
  • [2] Forgotten exogenous corticosteroid as a cause of central serous chorioretinopathy
    Hardwig, Paul W.
    Silva, Amila O.
    Pulido, Jose S.
    CLINICAL OPHTHALMOLOGY, 2008, 2 (01): : 199 - 201
  • [3] Intravitreal Ranibizumab for Acute Central Serous Chorioretinopathy
    Lee, Seung Jun
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [4] Salivary steroids in acute central serous chorioretinopathy
    Dmitrii S. Maltsev
    Alexei N. Kulikov
    Alexander S. Vasiliev
    Jay Chhablani
    International Ophthalmology, 45 (1)
  • [5] Intravitreal Ranibizumab for Acute Central Serous Chorioretinopathy
    Kim, Moosang
    Lee, Seung-Chan
    Lee, Seung-Jun
    OPHTHALMOLOGICA, 2013, 229 (03) : 152 - 157
  • [6] Light exposure in acute central serous chorioretinopathy
    Norouzpour, Amir
    EYE, 2022, 36 (01) : 243 - 243
  • [7] Light exposure in acute central serous chorioretinopathy
    Amir Norouzpour
    Eye, 2022, 36 : 243 - 243
  • [8] Acute central serous chorioretinopathy and fundus autofluorescence
    Eandi, CM
    Ober, M
    Iranmanesh, R
    Peiretti, E
    Yannuzzi, LA
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2005, 25 (08): : 989 - 993
  • [9] Acute Transverse Myelitis with Central Serous Chorioretinopathy
    Song, Hyun Seok
    Seo, Seong Don
    Park, Jin-Sung
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (07) : 951 - 951
  • [10] CENTRAL SEROUS CHORIORETINOPATHY
    Samalia, Priya
    Chong, Cheefoong
    Riley, Andrew
    Squirrell, David
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2015, 43 : 111 - 112